Hasil Pencarian - Lakshminarayanan Nandagopal

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results

    385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results oleh Ajay Gopal, Mahesh Seetharam, Alex Adjei, Linda Lee, Wael Harb, Jordan Berlin, Yan Xing, Paul Swiecicki, Lakshminarayanan Nandagopal, Cong Xu, Yuan Meng, Yonggang Zhao, Zhengyi Wang, Joan Huaqiong Shen

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Obesity diminishes response to PD-1-based immunotherapies in renal cancer

    Obesity diminishes response to PD-1-based immunotherapies in renal cancer oleh Peng Li, Amani Makkouk, Jennifer Gordetsky, Eddy Yang, Lewis Thomas, Lakshminarayanan Nandagopal, Hesham Yasin, Rohan Garje, Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson, William James Turbitt, Gal Wald, Claire Buchta Rosean, Katlyn E Norris, Megan Bing, Laura Bertrand, Brett P Gross, Dmytro Starenki, Kristine I Farag, Robert E Sorge, James A Brown, David M Lubaroff, Rebecca C Arend, Kenneth Nepple, Tatiana T Marquez-Lago, Lyse A Norian

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: